• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Journal Scan: Anticoagulant rodenticide screening may help determine prognosis

April 22, 2013
Jennifer L. Garcia, DVM, DACVIM

This study looked at whether such a screening is worth it and what it means if the results are negative.

Why they did it

When a patient is presented for evaluation of lethargy, collapse, decreased appetite, vomiting, dyspnea, or coughing, you might suspect rodenticide exposure. Is it worth it to perform a screening for common anticoagulants to predict the prognosis? And what does it mean for a patient if the results of such a screening are negative?

What they did

In a retrospective case series, researchers evaluated the results of anticoagulant rodenticide screening tests submitted to a veterinary diagnostic laboratory from January 1996 through January 2003. In addition to anticoagulant rodenticide testing results and physical examination findings, the following were recorded in patients selected for inclusion in this study: packed cell volume (PCV), total solids concentration, prothrombin time (PT), activated partial thromboplastin time (aPTT), platelet count, detailed treatment history, final diagnosis, and outcome.

Anticoagulant rodenticide screening included high-performance liquid chromatography analysis for:

Advertisement
  • Brodifacoum

  • Bromadiolone

  • Chlorophacinone

  • Coumafuryl

  • Dicoumarol

  • Difenacoum

  • Difethialone

  • Diphacinone

  • Pindone

  • Valone

  • Warfarin

What they found

Among the 123 dogs tested, 75 (61%) had positive test results for anticoagulant rodenticide; 21 (28%) of these had no known toxin exposure. Anticoagulant rodenticide concentrations ranged from trace amounts to 1,120 parts per billion. The researchers found that anticoagulant rodenticide concentrations did not correlate with the severity of the clinical signs or degree of prolongation of coagulation times. The authors note that the lack of correlation between anticoagulant rodenticide concentrations and clinical sign severity may have been related to timing of the sample draw or previous therapy.

There was no difference in the most common initial clinical signs (lethargy or collapse, decreased appetite, vomiting, dyspnea, and cough) between the groups with positive and negative test results. The median PCV, total solids concentration, platelet count, and aPTT were also similar between the two groups, whereas initial median PT was significantly longer among dogs in the positive group (52 vs. 13 seconds, P < 0.001).

For those dogs that had negative results for the anticoagulant rodenticide testing (n = 48), the most common conditions diagnosed were neoplasia (31.3%), immune-mediated disease (14.6%), and gastrointestinal bleeding (10.4%). More dogs that had positive results survived compared with those with negative test results (98% vs. 63%, P < 0.001).

Take-home message

Anticoagulant rodenticide screening may allow clinicians to guide treatment decisions since severe coagulopathy and negative results for anticoagulant rodenticide screening were associated with a poor prognosis. For these patients, consider a work-up for underlying diseases such as neoplasia, liver failure, or immune-mediated thrombocytopenia.

Waddell LS, Poppenga RH, Drobatz KJ. Anticoagulant rodenticide screening in dogs: 123 cases (1996-2003). J Am Vet Med Assoc 2013;242(4):516-521.

Link to abstract: http://avmajournals.avma.org/doi/abs/10.2460/javma.242.4.516

Related Content:

Clinical
3 Must-reads for National Poison Prevention Week
3 Must-reads for National Poison Prevention Week
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman
Dr Natalie Marks to lecture on diabetes management with Dr Adam Christman
3 concerns with homemade diets for pets
3 concerns with homemade diets for pets

Advertisement

Latest News

Xylazine moves from the stables to the streets

DEA reports widespread threat of fentanyl mixed with xylazine

3 Must-reads for National Poison Prevention Week

UC Davis study on eye diseases in kittens

View More Latest News
Advertisement